Potential human immunotherapeutics for plague.
Andrianaivoarimanana V, Randriantseheno LN, Moore KM, Walker NJ, Lonsdale SG, Kempster S, Almond NA, Rajerison M, Williamson ED.
Andrianaivoarimanana V, et al. Among authors: walker nj.
Immunother Adv. 2021 Oct 5;1(1):ltab020. doi: 10.1093/immadv/ltab020. eCollection 2021 Jan.
Immunother Adv. 2021.
PMID: 35919741
Free PMC article.
Review.